Wearable Neurofeedback Startup BRYM Secures €650K to Build Next-Generation Brain Training Platform

European neurotechnology startup BRYM has closed a €650,000 funding round to accelerate development of its wearable neurofeedback platform, according to reporting from Tech.eu. The raise arrives at a moment when the broader neurofeedback sector is drawing renewed attention from both clinical and consumer-facing investors, and it underscores the growing conviction that real-time brain state monitoring can be packaged into accessible, everyday hardware.

The Technology

Neurofeedback platforms operate on a well-established principle: by giving users real-time data about their own brain activity, typically derived from electroencephalography signals, these systems allow individuals to learn, over repeated sessions, how to self-regulate specific neural patterns associated with attention, relaxation, or emotional states. What has historically kept neurofeedback confined to clinical settings is the complexity and cost of the hardware involved. BRYM's wearable approach is aimed squarely at removing those barriers, translating the core feedback loop into a form factor that users can engage with outside of a hospital or therapy room. While specific technical details about the device's electrode configuration or signal processing pipeline have not been disclosed, the company's positioning suggests an emphasis on usability and portability as primary design drivers.

Market Context

BRYM's raise lands against a backdrop of genuine momentum in the neurofeedback space. Precedence Research projected earlier this year that the global neurofeedback systems market would sustain significant expansion through 2035, reflecting demand across education, mental health, and performance optimization verticals. That commercial trajectory has already attracted other entrants: Excellent Brain recently announced a partnership with Scholas Occurrentes to bring ADHD-focused neurofeedback training into schools and universities across multiple continents. The convergence of these moves points to a sector that is actively working through a transition from specialized clinical tool to scalable platform technology. For BRYM, securing early capital now positions the company to iterate on hardware and software before the market becomes substantially more crowded.

What's Next

A €650,000 seed-level raise is modest by the standards of the broader neurotechnology funding landscape, where larger rounds backed by institutional names like Bezos Expeditions and Google Ventures have set a high-water mark for visibility. However, early-stage capital at this scale is frequently where the most consequential product decisions get made, and BRYM will need to use the runway efficiently to demonstrate clinical or behavioral efficacy that can support a larger Series A conversation. Regulatory pathways will also require careful navigation, particularly if the platform makes any claims that edge toward therapeutic rather than purely wellness applications. If BRYM can deliver compelling real-world outcomes data, its progress could serve as a meaningful proof point for the proposition that wearable neurofeedback is ready to move from niche interest to mainstream adoption.